You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

 

709 Results
Document
Mar 2018
Guidelines and Advice
Status: In-Review
ID: 6-13
Mar 2018
Document
Dec 1969
Document
Dec 1969
Document
Dec 1969
Document
Dec 1969
Drug
Other Name(s): Oncaspar®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Dec 1969
Guidelines and Advice
Status: Current
Version: 2
Dec 1969
Guidelines and Advice
Status: Current
ID: PET 2017-2
Version: n/a
Dec 1969
Regimen
Cancer Type:
Lung, 
Non-Small Cell
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - In Combination with Platinum and Pemetrexed for First Line Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
pemetrexed
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Document
Jul 2018
Guidelines and Advice
Status: Current
Version: 1
Dec 1969

Pages